ITGAM and neoplasm: The observation that ICAM-1 did not compensate for lack of CD11b-mediated adhesion in EO-tumor cell conjugates upon CD11b/CD18 blockade further supports the major role played by CD11b/CD18 in mediating tumor cell adhesion and subsequent cytotoxicity in IL-33 EO.